Company / Profit Margin
Vanda Pharmaceuticals Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
1.3%
FY2025
5-year range
1.3% / 50.9%
FY2021-FY2025
Trend
-47.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -36.3% in FY2017 to 50.9% in FY2021.
Based on SEC 10-K filings.
1.3% in FY2025 with a 5-year CAGR of -11.8%.
Declined from 12.3% to 1.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -8.1pp
- 5-Year Change
- -11.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 47.4% year-over-year.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.3% | -47.4% |
| FY2024 | 2.5% | -80.0% |
| FY2023 | 12.3% | +31.3% |
| FY2022 | 9.4% | -81.5% |
| FY2021 | 50.9% | +289.7% |
| FY2020 | 13.1% | +238.4% |
| FY2019 | -9.4% | +23.5% |
| FY2018 | -12.3% | +66.0% |
| FY2017 | -36.3% | -190.1% |
| FY2016 | 40.3% | +164.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026